Cancer Causes & Control

, Volume 25, Issue 10, pp 1423–1426 | Cite as

Breast screening: an obsessive compulsive disorder

  • Yunus A. Luqmani


Population-based mammographic screening, founded on the premise that ‘early is better than late,’ has been adopted in several countries but has been the subject of controversy since its inception. Findings and interpretation of clinical trials data vary considerably, with disagreement on the outcome and value of such a procedure. In recent years, misgivings are being voiced from many quarters, not just about the benefits but about the potential harms of mass screening. The many are being screened for the benefit of the few. Even this might be acceptable,  but the realization that a significant proportion of women with screen detected cancers that will potentially not cause them harm, and who are very likely receiving unnecessary treatment, has sparked further concern. Many are calling for re-assessment of the age of commencement and periodicity if not complete cessation of indiscriminate screening. An aspect of great concern is that screening is being vigorously advocated by many healthcare workers, the media, and lay persons alike without proper awareness or appreciation of the consequences. Although some National Health Department leaflets are now presenting a truer picture, there is still a distinct lack of transparency to allow women to distinguish perception from reality and to make informed choices. How many would elect to be screened if they knew that for every one woman who is notionally saved by early detection, anywhere from 2 to 10 otherwise healthy women are being turned into breast cancer patients?


Breast cancer Mammography Breast screening Clinical trials 


Conflict of interest

The author declares that he has no conflict of interest.


  1. 1.
    Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367:1998–2005PubMedCrossRefGoogle Scholar
  2. 2.
    My medical choice by Angelina Jolie (2013) Accessed 9 Jan 2014
  3. 3.
    Gigerenzer G (2014) The Art of Risk Communication. Breast cancer screening pamphlets mislead women. BMJ 348:g2636PubMedCrossRefGoogle Scholar
  4. 4.
    The Susan G. Komen Breast Cancer Foundation. Consolidated financial statements and supplemental schedules. Accessed 9 Jan 2014
  5. 5.
    Baum M (2013) Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ 346:f385PubMedCrossRefGoogle Scholar
  6. 6.
    Kalager M, Adami HO, Bretthauer M, Tamimi RM (2012) Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 156(7):491–499PubMedCrossRefGoogle Scholar
  7. 7.
    Cowan WK, Angus B, Gray JC, Lunt LG, Al-Tamimi SR (2000) A study of interval breast cancer within the NHS breast screening programme. J Clin Pathol 53:140–146PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    US Preventive Services Task Force (2009) Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 151(10):716–726CrossRefGoogle Scholar
  9. 9.
    Top Mammography Experts Voice Outrage Over New Breast Cancer Screening Recommendations Radiological Society of North America (RSNA) 95th Scientific Assembly and Annual Meeting. Accessed 11 Jun 2014
  10. 10.
  11. 11.
    Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM (2013) Registry-based Study of Trends in Breast Cancer Screening Mammography before and after the 2009 US Preventive Services Task Force Recommendations. Radiology. doi: 10.1148/radiol.13131063 PubMedGoogle Scholar
  12. 12.
    The Canadian Task Force on Preventive Health Care (2011) Recommendations on screening for breast cancer in average-risk women aged 40–74 years. CMAJ 183(17):1991–2001PubMedCentralCrossRefGoogle Scholar
  13. 13.
    Bewley S (2011) Breast cancer screening. The NHS breast screening programme needs independent review. BMJ 343:d6894PubMedCrossRefGoogle Scholar
  14. 14.
    Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380:1778–1786CrossRefGoogle Scholar
  15. 15.
    Gøtzsche PC, Nielsen M (2009) Screening for breast cancer with mammography. Cochrane Database Syst Rev 4:CD001877. doi: 10.1002/14651858.CD001877.pub3 PubMedGoogle Scholar
  16. 16.
    EUROSCREEN Working Group (2012) Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. Med Screen 19(Suppl 1):5–13. doi: 10.1258/jms.2012.012077 Google Scholar
  17. 17.
    Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B (2010) Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control 2:275–282CrossRefGoogle Scholar
  18. 18.
    Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E, EUROSCREEN Working Group (2012) Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 19(Suppl 1):42–56PubMedCrossRefGoogle Scholar
  19. 19.
    Jørgensen KJ, Gøtzsche PC (2009) Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 339:b2587PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348:g366. doi: 10.1136/bmj.g366 PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ (2011) Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 33(1):111–1121PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Levman J (2014) Re: accusations of bias versus actual bias regarding mammography. Br Med J 348:g366CrossRefGoogle Scholar
  23. 23.
    Gøtzsche PC (2012) “Benefit and harms of mammography screening, and invitations to screening, Written statement for the UK hearing on mammography screening, 8 March 2012”, Accessed 12 Jun 2014
  24. 24.
    Eusebi V, Feudale E, Foschini MP, Micheli A et al (1994) Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11:223–235PubMedGoogle Scholar
  25. 25.
    NHS breast screening: helping you decide. Accessed 12 Jan 2014
  26. 26.
    Breast Screening Programme, England 2009–10 (2014). Accessed 12 Jan 2014

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  1. 1.Faculty of PharmacyKuwait UniversityKuwait CityKuwait

Personalised recommendations